Allakos has announced that it's ENIGMA (Phase 3) and KRYPTOS (Phase 2/3) studies for lirentelimab in EG & EoD and EoE respectively met histologic endpoints but missed symptomatic endpoints. Read more
The US FDA has rejected an application for TAK-721 (budesonide oral suspension) for the treatment of EoE in it's present form, and have recommended an additional study to help resolve feedback. Read more
Two opportunities are available, a Post-Doctoral Researcher and Research Assistant, in the Allergy, Inflammation & Remodelling Research (AIRR) Laboratory of Dr. Joanne Masterson at Maynooth University, Northern Ireland. Read more
Nov 2020 - Growing evidence that Eosinophilic Gastritis and Eosinophilic Gastroenteritis are under-diagnosed. 58% of moderate-severely symptomatic patients without diagnoses who entered the ENIGMA study met histologic criteria for EG/EGE Read more
Mar 2021 - Phase 3 trial shows Dupilimab to improve health-related quality of life and reduces symptom burden in patients with EoE. Read more
Mar 2021 - Study finds Budesonide Oral Suspension improves multiple outcomes for children 11-17 with EoE. The drug taken twice-daily improved histologic, endoscopic, and combined histologic and symptomatic outcomes in children with EoE. Read more
Jan 2021 - The International Eosinophil Society (IES) is holding a virtual seminar on 'Eosinophils and COVID'. Talks will include the involvement of eosinophils in viral infections, Covid-19 and eosinophilic diseases, and vaccine hypersensitivity. Read more
Dec 2020 - AstraZeneca has begun its Phase 3 trial evaluating Fasenra in EoE and other eosinophilic diseases. It has also announced a further Phase 3 trial evaluating the drug for EG and EGE. Read more
Nov 2020 - Allakos have published the results of the ENIGMA Phase 2 study of Lirentelimab for EG and EGE patients, showing meaningful and statistically significant benefits. The study appears in the October 2020 edition of the NEJM Read more
Oct 2020 - Dupixent® (dupilumab) Late-breaking Pivotal Data Showing Significant Improvement in Eosinophilic Esophagitis Signs and Symptom Read more
May 2020 - USA National Institute of Health Support Research In Covid-19 and Rare Diseases Including Eosinophilic Diseases- Read the full article here Read more
Feb 2020 - Research into blood and tissue markers for EG Eosinophilic Disease study published by CEGIR. Read more